Related Experiment Videos
Irritable bowel syndrome in Mexico.
I Huerta1, M A Valdovinos, M Schmulson
1Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15 Tlalpan, CP 14000 Mexico City, Mexico.
Digestive Diseases (Basel, Switzerland)
|December 26, 2001
Summary
Irritable bowel syndrome (IBS) in Mexico shows prevalence and characteristics similar to international findings. This suggests Mexico is a suitable location for conducting clinical trials on IBS.
Area of Science:
- Gastroenterology
- Epidemiology
- Clinical Research
Background:
- Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disorder.
- Understanding IBS epidemiology and clinical presentation in diverse populations is crucial.
Purpose of the Study:
- To systematically review and synthesize available original data on irritable bowel syndrome (IBS) in Mexico.
- To assess the comparability of Mexican IBS data with international literature.
Main Methods:
- Systematic review of original data on IBS in Mexico.
- Inclusion of 18 papers, primarily published between 1996 and 2000.
- Data organized by prevalence, gender, healthcare utilization, psychosocial factors, diagnostics, bowel habits, physiology, clinical trials, and quality of life.
Main Results:
- The review synthesized data on various aspects of IBS in Mexico.
- Key areas analyzed included prevalence, gender distribution, and psychosocial factors.
- The majority of included studies were published in the late 1990s.
Conclusions:
- Irritable bowel syndrome in Mexico shares similarities with international reports across analyzed domains.
- The findings support the feasibility of conducting clinical trials for IBS in Mexico with comparable outcomes to other regions.